Previous studies have shown that anti-colorectal cancer mAbs with plant-specific glycostructures had similar in vitro interactions of Fc and the Fc Receptor I (CD64) to their parental mAbM[7], [35] and in vivo anti-tumor activity [36]. This evidence concerns the gene FCGR1A and colorectal cancer.